Janssen Receives Positive CHMP Opinion for SPRAVATO® (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder - Business Wire
Submitted by Anonymous (not verified) on Fri, 12/11/2020 - 11:57